Tylvax® C Px

Premix

Advanced-generation and Broad-spectrum Tetracycline - Macrolide Synergyc Association
Poultry Swine

Formulation

Tilvalosin (as tartrate) 20.00 mg, Chlortetracycline (as hydrochloride) 200.00 mg, Excipients 1.00 g.

Indications

For the treatment and prevention of digestive and respiratory diseases caused by microorganisms sensitive to tylvalosin and chlortetracycline, mainly mycoplasmosis respiratory disease in poultry, swine enzootic pneumonia, swine dysentery and ileitis. The addition of chlortetracycline increases the effect of the antibiotic, enhancing its action and expanding its range to mixed infections with Gram negative microorganisms.

Tylvalosin is a new macrolide antibiotic with high efficiency, up to 10 times the tylvalosin resulting of this a superior antimycoplasmal efficacy. Tilvax C Px provides faster absorption, better bioidisponibilidad and higher concentrations in blood than those achieved with the tylvalosin, ensuring a wide distribution to specific areas and pulmonary airway blood. Chlortetracycline belongs to the group of tetracyclines and acts bacteriostatic against many Gram positive and negative bacteria.

Dosage and Administration

Poultry (chickens, turkeys and cocks replacement): preventive against infections caused by Mycoplasma gallisepticum, M. synoviae, the mixture of the two or mixed infections with Gram negative microorganisms: 1kg/TM food. Therapeutic: 2.5 kg / MT of feed. Pigs: preventive against swine enzootic pneumonia, swine dysentery and porcine ileitis mixed infections: 1 - 2.5 kg / MT of feed. Therapeutic: 2.5 - 4 kg / MT of feed.

Commercial Presentation

Box x 20 kg, Jar x 1 Kg, Jar x 100 g, Bag x 100 g,

SENASA Registry

F0370N1689